#United States #Sarasota #ophthalmology #NanoFil™ #microinjection

World Precision Instruments Expands NanoFil™ Syringe Family

World Precision Instruments (WPI), a renowned name in laboratory instruments and research tools for life sciences, recently announced the addition of new syringe sizes in its NanoFil™ line, specifically designed for ultra-low-volume delivery. The new syringe options, measuring 5µL, 25µL, and 50µL, are set to provide researchers with unprecedented flexibility, accuracy, and improved dosing capabilities for diverse applications such as ophthalmology and neuroscience.

Revolutionizing Microinjection with Versatile Syringe Sizes

The newly introduced syringes enhance the already successful NanoFil™ range, allowing researchers to utilize the most appropriate volume for their specific needs. The 5µL syringe, in particular, is a breakthrough for the field, addressing the increasing demand for precise injections of minimal volumes. This remarkable syringe offers critical advantages in terms of reagent conservation and tissue preservation, especially when working with sensitive samples.

Researcher Brittany Crafton, WPI’s Product Manager, emphasized the importance of accurate microinjection tools, stating, "Researchers working with valuable media need injection tools that deliver precisely with confidence." The handheld 5µL syringe further allows for individual control during delicate procedures, solving challenges faced in the ophthalmology research sector, which previously lacked an effective handheld delivery system.

Furthermore, Crafton shared her excitement about moving toward the development of such innovative tools, highlighting the lack of options for researchers striving for even finer dosage precision, such as 0.25µL in neuroscience applications.

Enhanced Features for Maximum Performance

WPI’s NanoFil™ syringes are specifically designed with a gas-tight, zero-dead-volume mechanism that optimizes sample recovery while ensuring highly reproducible injections. This unique feature sets the NanoFil™ syringes apart, as they are the only syringes on the market where the needle connects directly to the glass barrel, forming a vacuum seal once primed.

This design eliminates the common issues associated with syringes using a continuous Teflon piston, making them a cost-effective choice for researchers. Available in either blunt or tri-bevel tips with gauge sizes ranging from 33G to 36G, these syringes ensure minimal trauma during insertion and removal, making them ideal for sensitive tissues.

Applications and Future Prospects

The expanded lineup of NanoFil™ syringes makes it easier for researchers to select the volume that best caters to their experimental requirements, creating compatibility within the already established NanoFil™ ecosystem. Applications of the new syringe sizes range significantly from:

• - Retinal gene therapy
• - Intravitreal and subretinal injections
• - Optogenetics
• - CRISPR-based therapeutics
• - Cell-based therapies
• - Stereotaxic brain injections
• - Ocular drug delivery research
• - Neuroscience and neurobiology studies

As research continues to evolve toward more sophisticated therapies like gene editing and RNA-based treatment, the requirement for accurate micro-delivery systems will only increase. WPI’s innovative solutions are designed specifically for the unique challenges faced by researchers in sensitive experimental setups.

With the addition of the 5, 10, 25, 50, and 100µL configurations in the NanoFil™ family, WPI ensures researchers can access tools that significantly enhance their experimental outcomes. For those interested in exploring these groundbreaking precision instruments, more information can be found on WPI's official website: www.wpiinc.com/nanofil.

About World Precision Instruments

For nearly six decades, WPI has been committed to advancing the field of life sciences. With a broad array of precision instruments and laboratory equipment, the company continues to support critical research in neuroscience, physiology, cell biology, and ophthalmology through its innovative offerings.